CONFERENCE DAY two
SEPTEMBER 10, 2025
SHOWCASE YOUR SCIENCE CONTINUED
7:30 – 8:30 One-on-One PartneringTM portal meeting schedule starts. Arrive early to grab a coffee and meet with key contacts in bookable meeting spaces before the conference begins.
7:30 am Chair’s Opening Remarks
Target Selection & Novel Conjugates
Synopsis
Opportunities to be First-in-Class & Differentiate through Design, to More Selectively Target or Effectively Internalize Payloads into Target Cells
8:40 am Session Reserved for GO Therapeutics
9:00 am Session Reserved for MaveriX
9:30 – 11:30 One-on-One Meeting Schedule Available During Extended Break
Synopsis
With Day One an opportunity to establish connections and break the ice, leverage extended breaks during Day Two’s schedule to sit down with slide decks and make a lasting impression. Beyond the breaks, gain insiders insights into how business leaders across payloads, novel conjugates, linker conjugation, and target selection technologies are creatively shaping deal-making and prioritizing science that’s poised to lead in the race for first- or best-in-class.
9:40 am Morning Break & Networking
11:40 am Opportunity to be First-in-Class: Considerations for Collaborations with New Targets
Synopsis
- What are the economics of having a new target for others to develop an ADC around?
- Discussing opportunities to be first-in-class pursuing underexploited targets
- Debating the decision to leverage the best linker-payload platform or off-patent technologies, considering the influence on the side effect profile
12:15 pm Lunch Break & Networking
12:30 – 2:00 One-on-One Meeting Available During Extended Lunch
2:10 pm Increasing Tissue Penetration & Limiting Immunogenicity: Differentiating Through Novel Conjugate Design
Synopsis
- Targeting proteins expressed in a larger number of cancers versus receptors predominantly expressed in solid tumor subsets
- Increasing tissue penetration propensity to achieve more significant internalization and intracellular exposure to the payload with smaller proteins
- Leveraging reduced screening cycles required to optimize linker chemistry with smaller proteins, and modulatory to conjugate different payload types
ADC Deal-Making: Experience & Economics of Successful Partnerships in ADCs
2:45 pm ADC Deal-Making: Will Success Lead to More Success?
Synopsis
- Discussing opportunity for and examples of creative deal structures across ADCs
- For payloads: Do you need the full ADC payload for a deal?
- For linkers: What drives deals with different types of linkers?
- For target discovery: What are the differences in deal structure versus linkers and payloads?
- Sharing guidance to progress from a research collaboration to a licensing agreement, and deal structure including direction for upfront milestones and royalties